A number of xanthone derivatives bearing the basic chain of naftifine and butenafine antimycotics in 1, 2, 3, and 4 nuclear positions are described. The in vitro antifungal activity against representative strains of molds and yeasts is reported. Only butenafine xanthone analogues shaw significant activity against Cryptococcus neoformans, in particular the regioisomer 4d (1.5 mu g/ml).
A number of xanthone derivatives bearing the basic chain of naftifine and butenafine antimycotics in 1, 2, 3, and 4 nuclear positions are described. The in vitro antifungal activity against representative strains of molds and yeasts is reported. Only butenafine xanthone analogues shaw significant activity against Cryptococcus neoformans, in particular the regioisomer 4d (1.5 mu g/ml).
A number of xanthone derivatives bearing the basic chain of naftifine and butenafine antimycotics in 1, 2, 3, and 4 nuclear positions are described. The in vitro antifungal activity against representative strains of molds and yeasts is reported. Only butenafine xanthone analogues shaw significant activity against Cryptococcus neoformans, in particular the regioisomer 4d (1.5 mu g/ml).